Open in app

WHO will Provide Biological E. with mRNA Vaccination Technology.

Total Views:
Total Likes:
Published By:
Peeyush Ghalot
Published On:
(Image Courtesy: - UnityPoint Health)

Biological E. has been chosen by the World Health Organization's technology transfer centre to get mRNA technology. Following an evaluation of many bids from India, the WHO's Advisory Committee on Vaccine Product Development has picked Biological E. as a beneficiary. WHO and partners will collaborate with the Indian government and Biological E to design a plan and provide training and assistance to the firm so that it may begin manufacturing mRNA vaccines as soon as feasible. Since last year, the firm has been investing in mRNA technology, and the relationship with WHO will strengthen its potential to produce next-generation mRNA vaccines that may be more suited internationally and improve vaccine availability globally. mRNA vaccines employ a messenger RNA generated in a lab to instruct human cells how to manufacture a protein, which then triggers an immune response against a specific illness within the body. As soon as the virus enters the body, the immune system fights it. India currently lacks a COVID-19 vaccination based on the mRNA platform. COVID-19 vaccines from Pfizer-BioNTech and Moderna were created using mRNA technology.

Reference: -